Glycosuria: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 18: Line 18:
==Overview==
==Overview==


'''Glycosuria''' or '''glucosuria''' is an abnormal condition of [[osmotic]] [[diuresis]] due to excretion of [[glucose]] by the kidneys.
'''Glycosuria''' or '''glucosuria''' is an abnormal condition of [[osmotic]] [[diuresis]] due to excretion of [[glucose]] by the kidneys. The most common cause of glycosuria is untreated [[diabetes mellitus]]. The condition occurs when [[blood plasma|plasma]] glucose levels rise above kidney threshold for glucose reabsorption. At this point, the excess plasma glucose will not be reabsorbed in the proximal tubule and is excreted in the urine. When the excess glucose is excreted in the urine, it makes water enter the urine due to high osmolarity of the urine. This leads to the characteristic symptom of high urine volumes. Glycosuria can be either a physiologic response of the body to elevated blood glucose levels, such as alimentary glycosuria; or it can be a pathologic phenomenon. When glycosuria occurs at normal plasma glucose concentrations due to decreased renal threshold for glucose reabsorption, it is reffered to as [[renal glycosuria]]. Glycosuria has been targeted as a therapeutic option for diseases such as diabetes mellitus, as induction of glycosuria leads to better glycemic control and decreases risk of [[cardiovascular diseases]] in diabetic patients.


The most common cause of glycosuria is untreated [[diabetes mellitus]].  This disease raises [[blood plasma|plasma]] glucose levels far above normal, and beyond a certain threshold, the excess glucose is excreted by the kidneys, taking water with it and producing diuresis.  The threshold varies somewhat from one individual to another.
==Causes==
 
If the renal threshold for glycosuria is so low that even normal blood glucose levels produce the condition, it is referred to as ''[[renal glycosuria]].''


==Causes==
==== Conditions ====
'''Drugs Causing Glycosuria'''
* [[Diabetes mellitus]]
* Pregnancy
'''Drugs Causing Glycosuria<ref name=":1" />'''
*[[Chlorpromazine]]
*[[Chlorpromazine]]
*[[Cidofovir]]
*[[Cidofovir]]
Line 31: Line 31:
*[[Prednisolone]]
*[[Prednisolone]]
*[[Streptozocin]]
*[[Streptozocin]]
*[[ACE inhibitor|ACE]] Inhibitors ([[Captopril]], [[Enalapril]])
*[[SGLT2]] Inhibitors
'''Other chemicals causing glycosuria'''
* [[Ethanol]]
* [[Arsenic]]


==Historical Perspective==
==Historical Perspective==
*[Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
*Glycosuria was first discovered by von Mering and Minkowski in 1889.  
*In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
*In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].
   
   
==Classification==
==Classification==
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
:Glycosuria can be classified into the following groups, based on the etiology of glucose excretion in urine:
:*[group1]
:*Alimentary glycosuria
:*[group2]
:*Renal Glycosuria
:*[group3]
:*Diabetic glycosuria
*Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].
:*Iatrogenic glycosuria
:*Glycosuria as part of a syndrome or disease (e.g. [[Fanconi syndrome]] or [[Wilson disease]])
==Pathophysiology==
==Pathophysiology==
*The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
*The pathogenesis of glycosuria is characterized by either increased [[Blood sugar|plasma glucose]] or decreased proximal tubule threshold for glucose excretion.
*The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
*Genetic mutations can contribute to pathogenesis in glycosuria, especially renal glycosuria, these mutations include: [[SLC5A2]] and [[HNF1A]]<ref name=":1">{{Cite web|url=https://academic.oup.com/jcem/article/102/5/1548/2954944|title=Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>.  
*On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
*When plasma glucose levels exceed 180 mg/mL, the excess glucose will not be reabsorbed and is excreted in urine. However, proximal tubule threshold for glucose reabsorbtion varies among individuals and in difference stages of one's life span.
*On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
 
==Clinical Features==
Simultaneous excretion of glucose and water into urine leads to:
* [[Polyuria]]  
* [[polydipsia]]
 
==Differentiating Glycosuria from other Diseases==
*When excessive amounts of glucose is found in urine, the following diagnoses should be in mind:
:*Diabetes Mellitus
:*Renal glycosuria
:*Alimentary glycosuria
:*[[Fanconi syndrome]] (presence of glucose as well as other solutes in urine)
:*[[Wilson disease]]
 
Different causes of glycosuria can be differentiated based on:


==Clinical Features==
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! rowspan="2" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Disease}}
! colspan="5" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|History and symptoms}}
! colspan="8" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Laboratory findings}}
! rowspan="2" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Additional findings}}
|-
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Polyuria}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Polydipsia}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Polyphagia}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|="center" style="background:#DCDCDC;"|Weight loss}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Weight gain}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Serum glucose}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Urinary Glucose}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Urine PH}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Serum Sodium}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Urinary Glucose}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|24 hrs cortisol level}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|C-peptide level}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Serum glucagon}}
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus type 1|Type 1 Diabetes mellitus]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''''↑'''''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↓'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Auto antibodies present
([[GAD65|Anti GAD-65]] and anti insulin anti bodies)
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus type 2|Type 2 Diabetes mellitus]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acanthosis nigricans]]
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[MODY]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Transient [[hyperglycemia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |In hospitalized patients especially in [[ICU]] and [[CCU]]
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Steroid]] therapy
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acanthosis nigricans|Acanthosis nigricans,]]
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[RTA|RTA 1]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypokalemia]], [[nephrolithiasis]]
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Glucagonoma]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Necrolytic migratory erythema]]
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cushing's syndrome|Cushing syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↓'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]]
|}


==Differentiating [disease name] from other Diseases==
*[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
:*[Differential dx1]
:*[Differential dx2]
:*[Differential dx3]
==Epidemiology and Demographics==
==Epidemiology and Demographics==
* The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
* The prevalence of glycosuria in general population  is approximately 3000-5000 per 100,000 individuals worldwide<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1958671/|title=Prevalence of Glycosuria and Diabetes Mellitus|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>.
* In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].
* Prevalence of glycosuria is increasing due to:
** Increased incidence of DM.
** Increased use of medications such as SGLT2 inhibitors (in order to decreased blood glucose levels to reach a better glycemic control).
 
===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Patients of all age groups may develop glycosuria.
*[Disease name] is more commonly observed among patients aged [age range] years old.
*[Disease name] is more commonly observed among [elderly patients/young patients/children].
   
   
*As the patients' age increases, glycosuria increases due to decreased kidney threshold for glucose reabsorption<ref name=":2">{{Cite web|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1749121/|title=Renal glucose threshold variations with age|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>.
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Glycosuria affects both men and women.
*[Gender 1] are more commonly affected with [disease name] than [gender 2].
* The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
   
   
*Glycosuria is more common among males<ref name=":2" />.
===Race===
===Race===
*There is no racial predilection for [disease name].
*The incidence of glycosuria varies among different nationalities, however; there is no propensity to a specific race.
*[Disease name] usually affects individuals of the [race 1] race.
*[Race 2] individuals are less likely to develop [disease name].


==Risk Factors==
==Risk Factors==
*Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
*SLC5A2 mutation causes familial renal glycosuria<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pubmed/14569097|title=Molecular analysis of the SGLT2 gene in patients with renal glucosuria.|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
*Diabetes mellitus
*Exposure to medications or chemicals causing glycosuria.


== Natural History, Complications and Prognosis==
== Natural History, Complications and Prognosis==
*The majority of patients with [disease name] remain asymptomatic for [duration/years].
*Early clinical features include polyuria, polydipsia, [[hypoglycemia]] and weight loss due to excretion of glucose as a source of energy.
*Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
*Common complications of glycosuria include polyuria, polydipsia, and mild growth retardation.
*If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*Glycosuria increases as the patients age due to decreased renal threshold for glucose excretion<ref name=":0">{{Cite web|url=https://www.ncbi.nlm.nih.gov/pubmed/5141588|title=The prevalence and causes of glycosuria in 28,765 young men in the population in Singapore.|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>.
*Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
*Prognosis is generally excellent. There are no reports of mortality directly attributed to glycosuria.
*Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].


== Diagnosis ==
== Diagnosis ==
===Diagnostic Criteria===
===Diagnostic Criteria===
*The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
Diagnosis of glycosuria depends on the type of glycosuria:
:*[criterion 1]
 
:*[criterion 2]
For renal glycosuria<ref name=":0" />:
:*[criterion 3]
* Glycosuria in the face of normal blood glucose levels, normal glycosylated hemoglobin and normal free fatty acids
:*[criterion 4]
* Glycosuria independent of carbohydrate consumption
* No diabetic symptoms
For Alimentary glycosuria<ref name=":0" />:
* Normal fasting blood sugar
* Normal 2-hours post-prandial blood glucose
* Maximum blood glucose levels exceeding 180 mg/mL
Diabetic glycosuria:
* Glycosuria in the setting of known diabeties mellitus
:
=== Symptoms ===
=== Symptoms ===
*[Disease name] is usually asymptomatic.
*Symptoms of glycosuriamay include the following:
*Symptoms of [disease name] may include the following:
:*Polyuria
:*[symptom 1]
:*Polydipsia
:*[symptom 2]
:*Weight loss
:*[symptom 3]
:*[symptom 4]
:*[symptom 5]
:*[symptom 6]
   
   
=== Physical Examination ===
=== Physical Examination ===
*Patients with [disease name] usually appear [general appearance].
Patients with glycosuria generally appear normal in physical examination.
*Physical examination may be remarkable for:
 
:*[finding 1]
In specific conditions, such as pregnancy or starvation, patients may:
:*[finding 2]
* Appear dehydrated
:*[finding 3]
* Have ketosis
:*[finding 4]
:*[finding 5]
:*[finding 6]


=== Laboratory Findings ===
=== Laboratory Findings ===
*There are no specific laboratory findings associated with [disease name].
*Presence of glucose in urine sample.
 
*Blood sugar may or may not be elevated epending on the pathophysiology and the cause of glycosuria.
*Beside glucose, other solutes can be found in urine, depending on the  pathophysiology and the cause of glycosuria.


*A  [positive/negative] [test name] is diagnostic of [disease name].
*An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
*Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
===Imaging Findings===
*There are no [imaging study] findings associated with [disease name].
*[Imaging study 1] is the imaging modality of choice for [disease name].
*On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
*[Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].
=== Other Diagnostic Studies ===
=== Other Diagnostic Studies ===
*[Disease name] may also be diagnosed using [diagnostic study name].
*Microscopic urine analysis.
*Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
*Urine sample test for presence of glucose using [[glucose oxidase]] reagent strips.


== Treatment ==
== Treatment ==
=== Medical Therapy ===
=== Medical Therapy ===
*There is no treatment for [disease name]; the mainstay of therapy is supportive care.
*Tight glycemic control in cases of diabetes mellitus.
 
*The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
*[Medical therapy 1] acts by [mechanism of action 1].
*Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
=== Surgery ===
*Surgery is the mainstay of therapy for [disease name].
*[Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
*[Surgical procedure] can only be performed for patients with [disease stage] [disease name].
=== Prevention ===
=== Prevention ===
*There are no primary preventive measures available for [disease name].
*There are no primary preventive measures available for glycosuria except for that of glycemic control.
   
   
*Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
*Diet high in protein can lower the proportion of glucose in diet and reduce glucose excretion in urine<ref>{{Cite web|url=https://www.nejm.org/doi/full/10.1056/NEJM192002121820702|title=Diet Reduction with Retention of Protein to Relieve Glycosuria in Diabetes Mellitus|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>.


*Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].
==References==
==References==
{{Reflist|2}}
{{Reflist|2
}}
<references />
 
==See also==
==See also==
* [[Renal glycosuria]]
* [[Renal glycosuria]]


{{Abnormal clinical and laboratory findings}}
{{Abnormal clinical and laboratory findings}}


[[Category:Diabetes]]
[[Category:Diabetes]]

Latest revision as of 21:36, 24 January 2019

Template:SignSymptom infobox

WikiDoc Resources for Glycosuria

Articles

Most recent articles on Glycosuria

Most cited articles on Glycosuria

Review articles on Glycosuria

Articles on Glycosuria in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Glycosuria

Images of Glycosuria

Photos of Glycosuria

Podcasts & MP3s on Glycosuria

Videos on Glycosuria

Evidence Based Medicine

Cochrane Collaboration on Glycosuria

Bandolier on Glycosuria

TRIP on Glycosuria

Clinical Trials

Ongoing Trials on Glycosuria at Clinical Trials.gov

Trial results on Glycosuria

Clinical Trials on Glycosuria at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Glycosuria

NICE Guidance on Glycosuria

NHS PRODIGY Guidance

FDA on Glycosuria

CDC on Glycosuria

Books

Books on Glycosuria

News

Glycosuria in the news

Be alerted to news on Glycosuria

News trends on Glycosuria

Commentary

Blogs on Glycosuria

Definitions

Definitions of Glycosuria

Patient Resources / Community

Patient resources on Glycosuria

Discussion groups on Glycosuria

Patient Handouts on Glycosuria

Directions to Hospitals Treating Glycosuria

Risk calculators and risk factors for Glycosuria

Healthcare Provider Resources

Symptoms of Glycosuria

Causes & Risk Factors for Glycosuria

Diagnostic studies for Glycosuria

Treatment of Glycosuria

Continuing Medical Education (CME)

CME Programs on Glycosuria

International

Glycosuria en Espanol

Glycosuria en Francais

Business

Glycosuria in the Marketplace

Patents on Glycosuria

Experimental / Informatics

List of terms related to Glycosuria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Glycosuria or glucosuria is an abnormal condition of osmotic diuresis due to excretion of glucose by the kidneys. The most common cause of glycosuria is untreated diabetes mellitus. The condition occurs when plasma glucose levels rise above kidney threshold for glucose reabsorption. At this point, the excess plasma glucose will not be reabsorbed in the proximal tubule and is excreted in the urine. When the excess glucose is excreted in the urine, it makes water enter the urine due to high osmolarity of the urine. This leads to the characteristic symptom of high urine volumes. Glycosuria can be either a physiologic response of the body to elevated blood glucose levels, such as alimentary glycosuria; or it can be a pathologic phenomenon. When glycosuria occurs at normal plasma glucose concentrations due to decreased renal threshold for glucose reabsorption, it is reffered to as renal glycosuria. Glycosuria has been targeted as a therapeutic option for diseases such as diabetes mellitus, as induction of glycosuria leads to better glycemic control and decreases risk of cardiovascular diseases in diabetic patients.

Causes

Conditions

Drugs Causing Glycosuria[1]

Other chemicals causing glycosuria

Historical Perspective

  • Glycosuria was first discovered by von Mering and Minkowski in 1889.

Classification

Glycosuria can be classified into the following groups, based on the etiology of glucose excretion in urine:
  • Alimentary glycosuria
  • Renal Glycosuria
  • Diabetic glycosuria
  • Iatrogenic glycosuria
  • Glycosuria as part of a syndrome or disease (e.g. Fanconi syndrome or Wilson disease)

Pathophysiology

  • The pathogenesis of glycosuria is characterized by either increased plasma glucose or decreased proximal tubule threshold for glucose excretion.
  • Genetic mutations can contribute to pathogenesis in glycosuria, especially renal glycosuria, these mutations include: SLC5A2 and HNF1A[1].
  • When plasma glucose levels exceed 180 mg/mL, the excess glucose will not be reabsorbed and is excreted in urine. However, proximal tubule threshold for glucose reabsorbtion varies among individuals and in difference stages of one's life span.

Clinical Features

Simultaneous excretion of glucose and water into urine leads to:

Differentiating Glycosuria from other Diseases

  • When excessive amounts of glucose is found in urine, the following diagnoses should be in mind:

Different causes of glycosuria can be differentiated based on:

Disease History and symptoms Laboratory findings Additional findings
Polyuria Polydipsia Polyphagia Weight loss Weight gain Serum glucose Urinary Glucose Urine PH Serum Sodium Urinary Glucose 24 hrs cortisol level C-peptide level Serum glucagon
Type 1 Diabetes mellitus + + + + - Normal Normal N/ Normal Normal Auto antibodies present

(Anti GAD-65 and anti insulin anti bodies)

Type 2 Diabetes mellitus + + + + - Normal Normal Normal Normal Acanthosis nigricans
MODY + + + - + Normal Normal Normal Normal N -
Transient hyperglycemia - - - - - Normal Normal Normal Normal N/ In hospitalized patients especially in ICU and CCU
Steroid therapy + - - - + Normal Normal N/ N/ Acanthosis nigricans,
RTA 1 - - - + - Normal Normal Normal Normal Normal Normal Hypokalemia, nephrolithiasis
Glucagonoma - - - - - Normal Normal Normal - Normal Normal Necrolytic migratory erythema
Cushing syndrome - - - - + - Normal N/ Normal Normal Moon face, obesity, buffalo hump, easy bruisibility

Epidemiology and Demographics

  • The prevalence of glycosuria in general population is approximately 3000-5000 per 100,000 individuals worldwide[2].
  • Prevalence of glycosuria is increasing due to:
    • Increased incidence of DM.
    • Increased use of medications such as SGLT2 inhibitors (in order to decreased blood glucose levels to reach a better glycemic control).

Age

  • Patients of all age groups may develop glycosuria.
  • As the patients' age increases, glycosuria increases due to decreased kidney threshold for glucose reabsorption[3].

Gender

  • Glycosuria affects both men and women.
  • Glycosuria is more common among males[3].

Race

  • The incidence of glycosuria varies among different nationalities, however; there is no propensity to a specific race.

Risk Factors

  • SLC5A2 mutation causes familial renal glycosuria[4]
  • Diabetes mellitus
  • Exposure to medications or chemicals causing glycosuria.

Natural History, Complications and Prognosis

  • Early clinical features include polyuria, polydipsia, hypoglycemia and weight loss due to excretion of glucose as a source of energy.
  • Common complications of glycosuria include polyuria, polydipsia, and mild growth retardation.
  • Glycosuria increases as the patients age due to decreased renal threshold for glucose excretion[5].
  • Prognosis is generally excellent. There are no reports of mortality directly attributed to glycosuria.

Diagnosis

Diagnostic Criteria

Diagnosis of glycosuria depends on the type of glycosuria:

For renal glycosuria[5]:

  • Glycosuria in the face of normal blood glucose levels, normal glycosylated hemoglobin and normal free fatty acids
  • Glycosuria independent of carbohydrate consumption
  • No diabetic symptoms

For Alimentary glycosuria[5]:

  • Normal fasting blood sugar
  • Normal 2-hours post-prandial blood glucose
  • Maximum blood glucose levels exceeding 180 mg/mL

Diabetic glycosuria:

  • Glycosuria in the setting of known diabeties mellitus

Symptoms

  • Symptoms of glycosuriamay include the following:
  • Polyuria
  • Polydipsia
  • Weight loss

Physical Examination

Patients with glycosuria generally appear normal in physical examination.

In specific conditions, such as pregnancy or starvation, patients may:

  • Appear dehydrated
  • Have ketosis

Laboratory Findings

  • Presence of glucose in urine sample.
  • Blood sugar may or may not be elevated epending on the pathophysiology and the cause of glycosuria.
  • Beside glucose, other solutes can be found in urine, depending on the pathophysiology and the cause of glycosuria.

Other Diagnostic Studies

  • Microscopic urine analysis.
  • Urine sample test for presence of glucose using glucose oxidase reagent strips.

Treatment

Medical Therapy

  • Tight glycemic control in cases of diabetes mellitus.

Prevention

  • There are no primary preventive measures available for glycosuria except for that of glycemic control.
  • Diet high in protein can lower the proportion of glucose in diet and reduce glucose excretion in urine[6].

References

  1. 1.0 1.1 "Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria".
  2. "Prevalence of Glycosuria and Diabetes Mellitus".
  3. 3.0 3.1 "Renal glucose threshold variations with age".
  4. "Molecular analysis of the SGLT2 gene in patients with renal glucosuria".
  5. 5.0 5.1 5.2 "The prevalence and causes of glycosuria in 28,765 young men in the population in Singapore".
  6. "Diet Reduction with Retention of Protein to Relieve Glycosuria in Diabetes Mellitus".


See also

Template:Abnormal clinical and laboratory findings

de:Glucosurie nl:Glucosurie no:Glykosuri

Template:WH Template:WikiDoc Sources